Mark Kozloff to Transforming Growth Factor beta
This is a "connection" page, showing publications Mark Kozloff has written about Transforming Growth Factor beta.
Connection Strength
0.034
-
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer. Br J Cancer. 2018 11; 119(10):1208-1214.
Score: 0.034
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.